Castleview Partners, LLC Organon & Co. Transaction History

Castleview Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$13.78 - $18.8 $440 - $601	32 New	32 $0
Q3 2022 Nov 10, 2022	SELL	$23.4 - $34.25 $3,463 - $5,069	-148 Reduced 99.33%	1 $0
Q2 2022 Aug 17, 2022	SELL	$31.66 - $38.9 $124,550 - $153,032	-3,934 Reduced 96.35%	149 $5,000
Q2 2022 Aug 16, 2022	BUY	$31.66 - $38.9 $125,436 - $154,121	3,962 Added 3274.38%	4,083 $137,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $2,770 - $3,581	91 Added 303.33%	121 $4,000
Q4 2021 Feb 17, 2022	SELL	$28.67 - $37.13 $3,325 - $4,307	-116 Reduced 79.45%	30 $0
Q2 2021 Aug 17, 2021	BUY	$28.45 - $38.0 $4,153 - $5,548	146 New	146 $4,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.